Literature DB >> 35535320

Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia.

Koki Fujii1, Hideyuki Takeshima1, Taku Nishimura1, Toshio Sakatani1, Yoshio Masuda2, Teppei Morikawa2, Kazuhiro Usui1.   

Abstract

A 58-year-old woman with cough and dyspnea who was suspected of having idiopathic interstitial pneumonia had been treated with corticosteroids and cyclosporine, but the symptoms had worsened. There were no findings to suspect pulmonary alveolar proteinosis (PAP) in the bronchoalveolar lavage fluid, 17 months after the start of treatment. The transbronchial lung biopsy specimens showed eosinophilic bodies that strongly stained with periodic acid-Schiff staining. Anti-granulocyte macrophage colony-stimulating factor (anti-GM-CSF) antibodies were detected in her serum. We diagnosed the patient with autoimmune PAP. Thus, we present a rare case of PAP presenting atypical radiological images and bronchoalveolar lavage fluid findings.
© 2022 The Authors.

Entities:  

Keywords:  Anti-GM-CSF antibody; Autoimmune pulmonary alveolar proteinosis; Bronchoalveolar lavage fluid; Ground-glass opacities; Nonspecific interstitial pneumonia

Year:  2022        PMID: 35535320      PMCID: PMC9076885          DOI: 10.1016/j.rmcr.2022.101591

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by an abnormal accumulation of surfactants in the alveoli. Radiological images often show the abnormalities distributed predominantly in the perihilar regions [1]. Bronchoalveolar lavage fluid (BALF) from patients with PAP often has an opaque and milky appearance, which can confirm the diagnosis in approximately 75% of suspected cases [2]. Here we present a rare case of autoimmune PAP (APAP) with atypical radiological abnormalities and BALF findings.

Case report

As part of her physical examination 17 months ago, a 58-year-old woman underwent chest computed tomography (CT), which showed no abnormalities. Six months ago, she began to experience a persistent cough and dyspnea, for which she was prescribed 20 mg of prednisolone, but there was no response. Then, she was prescribed concomitant cyclosporine, but her condition worsened. The patient was admitted to our hospital for examination. She had no past medical history or family history of PAP, and she did not smoke, but she was taking estradiol and raloxifene to prevent menopausal disorders. The patient's physical examination revealed the following: height 155 cm, weight 44.3 kg, temperature 36.6 °C, blood pressure 150/101 mmHg, radial pulse 100 bpm, respiratory rate 14 bpm. Fine crackles were heard in both lungs. Lactate dehydrogenase (250 IU/L), Krebs von den Lungen-6 (KL-6 1329 U/mL), and lung surfactant protein D (211.5 ng/mL) levels were elevated. Arterial blood gas analysis in room air showed no hypoxemia (partial pressure of oxygen, 91.1 torr), and respiratory function tests revealed no abnormalities. Chest CT showed bilateral ground-glass opacities and reticular shadows, mainly distributed in the lower lobes. The abnormal shadows tended to enlarge over time after the initial examination (Fig. 1).
Fig. 1

Computed tomography images

(A) During the first visit, we observed bilateral ground-glass opacities with significant distribution in the peripheral regions. (B) Nine months after the first visit, the abnormal shadows had expanded to neighboring regions. (C) Seventeen months after the first visit, the abnormal shadows had spread in the center.

Computed tomography images (A) During the first visit, we observed bilateral ground-glass opacities with significant distribution in the peripheral regions. (B) Nine months after the first visit, the abnormal shadows had expanded to neighboring regions. (C) Seventeen months after the first visit, the abnormal shadows had spread in the center. Neither findings nor history were suggestive of hypersensitivity pneumonia, drug-induced pneumonia, eosinophilic pneumonia, or collagen vascular disease. Idiopathic interstitial pneumonia, including nonspecific interstitial pneumonia (NSIP), was suspected. Bronchoalveolar lavage was performed in the superior lingular segment of the left lobe, followed by a transbronchial lung biopsy (TBLB) of the left lower lobe. The BALF was transparent and did not have a milky appearance. The BALF cell count was unremarkable. The biopsy specimens contained eosinophilic bodies that strongly stained with periodic acid-Schiff (PAS) staining (Fig. 2).
Fig. 2

Transbronchial lung biopsy specimens stained with (A) hematoxylin and eosin and (B) periodic acid-Schiff staining. The biopsy specimens contained eosinophilic bodies that stained strongly with periodic acid-Schiff staining.

Transbronchial lung biopsy specimens stained with (A) hematoxylin and eosin and (B) periodic acid-Schiff staining. The biopsy specimens contained eosinophilic bodies that stained strongly with periodic acid-Schiff staining. The serum level of anti-granulocyte macrophage colony-stimulating factor (anti-GM-CSF) antibody was high at 74.0 U/mL (normal level <1.7). Based on these findings, the diagnosis of APAP was confirmed.

Discussion

We came across a rare symptomatic APAP case with NSIP-like radiological findings without a milky appearance of the BALF. PAP, first reported by Rosen et al., is a rare disorder where lipoproteins accumulate in the alveoli [3]. Clinically, PAP can be classified into three types: congenital, secondary, and autoimmune. Most cases of PAP are categorized into the autoimmune type, in which anti-GM-CSF antibodies are specifically detected [4]. In the diagnosis, BALF typically has a milky appearance. TBLB and surgical lung biopsies show eosinophilic bodies that stain strongly with PAS staining or surfactant protein A. Chest radiographs of patients with PAP generally show more pronounced abnormalities in the perihilar regions. Chest CT scans show air-space filling with a variable patchy distribution [1]. Our patient's chest CT showed bilateral ground-glass opacities and reticular shadows, mainly distributed in the lower lobes. Only 11 cases with a significant distribution in the peripheral regions have so far been reported in Japan (Table 1) [[5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]].
Table 1

Cases of pulmonary alveolar proteinosis (PAP) with a significant distribution of abnormal shadows in the peripheral regions.

CaseAgeSexSmokingSymptomsBALFDiagnosisAuthorYear
139FnevernotransparentBAL, TBLB, SLBInui1999
238FunknownnowhiteBAL, TBLBMita2003
355FnevernowhiteBAL, TBLBSugimoto2006
432FnevernowhiteBAL, TBLBMohri2007
558FnevernononeSLBTaniguchi2008
656FnevernotransparentBAL, TBLB, SLBYamazaki2008
745MnevernotransparentBAL, TBLB, SLBToyama2008
865FnevernoWhiteBAL, TBLBHaga2009
957MnevernoNoneSLBSunadome2010
1055FneverdyspneaWhiteBAL,TBLBSatoh2012
1141MnevernounknownBAL,TBLBSugino2019
Cases of pulmonary alveolar proteinosis (PAP) with a significant distribution of abnormal shadows in the peripheral regions. All cases, except for the case reported by Satoh [14], were asymptomatic. The case reported by Satoh was similar to our case in that the patient had symptoms that worsened with steroid and cyclosporine treatment. Although our case did not show the typical milky appearance of BALF, we diagnosed APAP by TBLB and by measuring the serum anti-GM-CSF antibody levels. In previous reports, bronchoalveolar lavage was performed in nine patients, and three out of nine patients (33.3%) showed no milky appearance in the BALF, as in our case. All three of these patients underwent invasive surgical lung biopsy (SLB) [5,10,11]. The measurement of anti-GM-CSF antibody levels at the early stage of this case would have been less invasive and useful for diagnosing PAP. In this case, we were able to shift from immune suppressant therapy to disease-specific therapy (such as total lung lavage) at an early stage when the lung function had not declined. Further investigation is necessary to elucidate the importance of anti-GM-CSF antibody measurements in cases with interstitial pneumonia. We reported a case of APAP with features similar to NSIP. Therefore, it is important to include PAP in the differential diagnosis, even in atypical cases.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors’ contributions

Koki Fujii wrote the manuscript. Hideyuki Takeshima, Taku Nishimura, Toshio Sakatani, and Kazuhiro Usui reviewed and edited the manuscript. Yoshio Masuda and Teppei Morikawa contributed to the pathological diagnosis.

Declaration of competing interest

The authors declare that they have no competing interests.
  12 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  Pulmonary alveolar proteinosis.

Authors:  S H ROSEN; B CASTLEMAN; A A LIEBOW
Journal:  N Engl J Med       Date:  1958-06-05       Impact factor: 91.245

3.  [A case of pulmonary alveolar proteinosis that showed solitary ground-glass opacity in the subpleural area].

Authors:  Hironobu Sunadome; Jun Nohara; Tetsuo Noguchi; Chisato Matsui; Tomoya Kono; Yasuji Terada
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2010-07

4.  [Early case of idiopathic pulmonary alveolar proteinosis positive for serum anti-GM-CSF antibody].

Authors:  Kei Yamasaki; Chiharu Yoshii; Chinatsu Nishida; Masamizu Kunimoto; Fumiyoshi Yoda; Toshinori Kawanami; Yasumasa Sakurai; Takehiro Nakamura; Kazuhiro Yatera; Masamitsu Kido
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2008-09

Review 5.  Diagnosing pulmonary alveolar proteinosis. A review and an update.

Authors:  B M Wang; E J Stern; R A Schmidt; D J Pierson
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

6.  [Radiological findings in initial pulmonary alveolar proteinosis detected in the post-treatment course of nocardiosis].

Authors:  Chikatoshi Sugimoto; Hideo Kobayashi; Soichiro Kanoh; Kazuo Motoyoshi; Shinsuke Aida
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2006-10

7.  [A case of idiopathic pulmonary alveolar proteinosis with multiple localized ground-glass opacities].

Authors:  Hirokazu Taniguchi; Hitoshi Abo; Masayoshi Touge; Hideki Shinnou; Hideki Miyazawa; Hirofumi Noto; Akio Uchiyama; Atsuo Miwa; Shoetsu Shimura; Saburo Izumi
Journal:  Arerugi       Date:  2008-08

Review 8.  Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor.

Authors:  Hironori Satoh; Ryushi Tazawa; Tomohiro Sakakibara; Shinya Ohkouchi; Masahito Ebina; Makoto Miki; Koh Nakata; Toshihiro Nukiwa
Journal:  Intern Med       Date:  2012-07-01       Impact factor: 1.271

Review 9.  [A case of pulmonary alveolar proteinosis presenting with peripheral ground-glass opacitiy].

Authors:  Takahiro Haga; Norio Kasamatsu; Takeshi Kobayashi; Masahiko Shibata; Takashi Ogasawara; Ikko Hashizume
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2009-01

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.